CTSL and ovarian cancer: High expression of CTSL was observed in 70.69% (41/58) of ovarian cancer specimens when compared with adjacent non-neoplastic tissues (32.76%, 19/58), the difference of CTSL expression was statistically significant (Figure 1B, P < 0.001), suggesting that CTSL may play an oncogenic role in ovarian cancer.